Overview
Alice Li is a Hematologist and an Oncologist practicing medicine in Oakland, California.
Her clinical expertise encompasses Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Large-Cell Lung Carcinoma.
Dr. Li is currently accepting new patients.
Specialties
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
3701 Broadway, 3rd Floor, Oakland, CA 94611
UCSF Benioff Children's Hospital Oakland
Elliott Vichinsky is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Vichinsky is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.
UCSF Benioff Children's Hospital Oakland
Ashutosh Lal is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Lal is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.
UCSF Benioff Children's Hospital Oakland
Mark Walters is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Walters is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Hemoglobinopathy, Congenital Hemolytic Anemia, Sickle Cell Disease, Hemolytic Anemia, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Alice C. Li
How do I make an appointment with Dr. Alice C. Li?
You can book an appointment with Dr. Alice C. Li by calling their office at 510-752-7780. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Alice C. Li a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alice C. Li is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Alice C. Li specialize in?
While Dr. Alice C. Li is a Hematology, they have specific expertise in Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Alice C. Li accept my insurance?
Dr. Alice C. Li accepts most major insurance plans, including Cigna and Kaiser Permanente. We recommend calling the office directly at 510-752-7780 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Li isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Li isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Li isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Li isExperienced. Learn about Lung Cancer.
- Nasopharyngeal CarcinomaDr. Li isExperienced. Learn about Nasopharyngeal Carcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Pleuropulmonary BlastomaDr. Li isExperienced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Li isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Li isExperienced. Learn about Squamous Cell Lung Carcinoma.